The Indian government announced plans to set price controls for at
least 400 essential drugs, about 60% of the country’s domestic
pharmaceuticals market. This represents a substantial increase from the
34 medicines—around 20–30% of the market—currently under government
price control. The proposal would also change the way prices of
controlled products are regulated, switching from a system where prices
are based upon market share to one that would set a price ceiling based
on the weighted average price of the top three brands. The move would
likely force dramatic price cuts on most imported brands subject to the
price controls.
Read more: